+1-518-621-2074 | US-Canada Toll Free Contact Us

Pancreatic Cancer Market Research Reports

about us

Pancreatic cancer originates from the transformed cells within the exocrine component of the same tissues found in the pancreatic region. It is among the most fatal cancers around the world. Its aggressive nature and inadequate responses to the several treatments poses as a major obstacle in the healing of such diseases. Pancreatic cancer is detected and diagnosed only when it is in its advanced stages. These stages are stage I, stage II, stage III, and stage IV of which stage I and II tumors are treatable and can be removed surgically.  

 

The uncontrolled growth of cells in the pancreas causes pancreatic cancer and this is further classified based on whether the cancer affects the endocrine or exocrine functions of the pancreas. This growth keeps on dividing forming a mass of tissues known as tumors. The most common type of pancreatic cancer is adenocarcinomas accounting about 95% of exocrine pancreatic cancers. 

 

Pancreatic cancer is ranked as the fourth leading cause of cancer deaths among men and women. This cancer is held responsible for causing 6% of all cancer-related deaths across the globe, and approximately 15-20% occurs in the body of the pancreas and 75% of all pancreatic carcinomas occur within the head or neck of the pancreas. 

 

According to the leading research and advisory pharmaceutical and healthcare firms, the global pancreatic cancer drug market is estimated to reach USD 1.2 billion by 2015 and get doubled to $1.3 billion by 2022. Among all the countries in the world, the United States has marked the maximum number of pancreatic cancer cases with around 30,000 patients getting affected every year. Today, the survival rate is less than 5 years which is like a major hurdle for the expansion of this market. 

 

To help you get a clear idea into the dynamics of this industry of pancreatic cancer, ResearchMoz brings you an entire database of well-informed market research reports by leading publishers. 

Pancreatic cancer originates from the transformed cells within the exocrine component of the same tissues found in the pancreatic region. It is among the most fatal cancers around the world. Its aggressive nature and inadequate responses to the several treatments poses as a major obstacle in the healing of such diseases. Pancreatic cancer is detected and diagnosed only when it is in its advanced stages. These stages are stage I, stage II, stage III, and stage IV of which stage I and II tumors are treatable and can be removed surgically.     The uncontrolled growth of cells in the pancreas ... Read More Hide

Displaying 1 to 10 (of 100 records)

Pancreatic Cancer Global Clinical Trials Review, H1, 2017

Mar 2017 | Pancreatic Cancer | 1492 Pages | $ 2500

View Report
China Pancreatic Cancer Pipelines Market Research Report 2017

Mar 2017 | Pancreatic Cancer | 96 Pages | $ 3200

View Report
Europe Pancreatic Cancer Pipelines Market Report 2017

Feb 2017 | Pancreatic Cancer | 100 Pages | $ 3900

View Report
United States Pancreatic Cancer Pipelines Market Report 2017

Feb 2017 | Pancreatic Cancer | 101 Pages | $ 3800

View Report
Global Pancreatic Cancer Pipelines Sales Market Report 2017

Feb 2017 | Pancreatic Cancer | 108 Pages | $ 4000

View Report
Global PancreatIc Cancer PIpelInes Market Research Report 2017

Feb 2017 | Pancreatic Cancer | 101 Pages | $ 2900

View Report
Global Pancreatic Cancer Partnering 2010 to 2017

Feb 2017 | Pancreatic Cancer | 150 Pages | $ 1495

View Report
Pancreatic Cancer - Epidemiology Forecast To 2023

Jan 2017 | Pancreatic Cancer | 60 Pages | $ 2750

View Report

Displaying 1 to 10 (of 100 records)

Search Filters

Search Filters Reset All

Key Regions Covered

Published Type

Select Price

Select Period

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074